CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Imidacloprid

吡虫啉 杂质对照品Imidacloprid Impurities

EP23 个杂质条目23 impurity entries

本页汇总 吡虫啉 的 23 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 23 impurity reference standards of Imidacloprid with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 吡虫啉(Imidacloprid)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesAssessment of imidacloprid induced genotoxicity in Pethia conchonius (Rosy barb), a common freshwater fish of India
    Drug and chemical toxicology · 2024 · Dutta D et al.  ·  PMID 37326304  ·  DOI
  2. 杂质研究Impurity studiesToxicity and genotoxicity of imidacloprid in the tadpoles of Leptodactylus luctator and Physalaemus cuvieri (Anura: Leptodactylidae)
    Scientific reports · 2022 · Samojeden CG et al.  ·  PMID 35831394  ·  DOI
  3. 杂质研究Impurity studiesGenotoxic effects of imidacloprid in human lymphoblastoid TK6 cells
    Drug and chemical toxicology · 2020 · Guo J et al.  ·  PMID 30103639  ·  DOI
  4. 分析方法Analytical MethodsDevelopment and Validation of a Stability-indicating Reversed-phase UPLC-UV Method for the Assay of Imidacloprid and Estimation of its Related Compounds
    Journal of chromatographic science · 2018 · Tian J, Rustum A  ·  PMID 29045600  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisTotal synthesis of (13) C(2) ,(15) N-imidacloprid with three stable isotopes in the pyridine ring
    Journal of labelled compounds & radiopharmaceuticals · 2019 · Belov V, Käfferlein HU  ·  PMID 30589452  ·  DOI

吡虫啉 —— 原料药与杂质对照品Imidacloprid — drug substance & impurities

共 24 个条目(含原料药本体)24 items incl. the drug substance
Imidacloprid structure
EP原料药 APIAPI
吡虫啉Imidacloprid
Imidacloprid
CAS No.138261-41-3
Chemical FormulaC9H10ClN5O2
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 2 (Imidacloprid EP Impurity B) structure
EPB
吡虫啉杂质2 (吡虫啉EP杂质B)Imidacloprid Impurity 2 (Imidacloprid EP Impurity B)
Imidacloprid Impurity 2 (Imidacloprid EP Impurity B)
CAS No.5465-96-3
Chemical FormulaC3H6N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 7 (Imidacloprid EP Impurity G) structure
EPG
吡虫啉杂质7 (吡虫啉EP杂质G)Imidacloprid Impurity 7 (Imidacloprid EP Impurity G)
Imidacloprid Impurity 7 (Imidacloprid EP Impurity G)
CAS No.135769-74-3
Chemical FormulaC9H9Cl2N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 1 structure
1
吡虫啉杂质1Imidacloprid Impurity 1
Imidacloprid Impurity 1
CAS No.380912-09-4
Chemical FormulaC9H10ClN5O3
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 9 structure
9
吡虫啉杂质9Imidacloprid Impurity 9
Imidacloprid Impurity 9
CAS No.120868-66-8
Chemical FormulaC9H10ClN3O
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 10 structure
10
吡虫啉杂质10Imidacloprid Impurity 10
Imidacloprid Impurity 10
CAS No.115086-54-9
Chemical FormulaC9H8ClN5O2
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 11 structure
11
吡虫啉杂质11Imidacloprid Impurity 11
Imidacloprid Impurity 11
CAS No.105828-41-9
Chemical FormulaC15H14Cl2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 17 (Mixture of E/Z-isomers) structure
17
吡虫啉杂质17 (混合E/Z构型)Imidacloprid Impurity 17 (Mixture of E/Z-isomers)
Imidacloprid Impurity 17 (Mixture of E/Z-isomers)
CAS No.330559-99-4
Chemical FormulaC13H20ClN5O4
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 18 structure
18
吡虫啉杂质18Imidacloprid Impurity 18
Imidacloprid Impurity 18
CAS No.155802-59-8
Chemical FormulaC13H20ClN5O4
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 19 structure
19
吡虫啉杂质19Imidacloprid Impurity 19
Imidacloprid Impurity 19
CAS No.1115248-04-8
Chemical FormulaC9H8ClN5O2
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 20 structure
20
吡虫啉杂质20Imidacloprid Impurity 20
Imidacloprid Impurity 20
CAS No.1575569-69-5
Chemical FormulaC7H8ClN5O2
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 21 structure
21
吡虫啉杂质21Imidacloprid Impurity 21
Imidacloprid Impurity 21
CAS No.1115248-03-7
Chemical FormulaC9H10ClN5O4
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 22 structure
22
吡虫啉杂质22Imidacloprid Impurity 22
Imidacloprid Impurity 22
CAS No.54127-31-0
Chemical FormulaC6H4Cl3N
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 23 structure
23
吡虫啉杂质23Imidacloprid Impurity 23
Imidacloprid Impurity 23
CAS No.330559-98-3
Chemical FormulaC7H16N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 26 structure
26
吡虫啉杂质26Imidacloprid Impurity 26
Imidacloprid Impurity 26
CAS No.915107-30-1
Chemical FormulaC7H6ClNO3
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 30 structure
30
吡虫啉杂质30Imidacloprid Impurity 30
Imidacloprid Impurity 30
CAS No.20076-62-4
Chemical FormulaC3H6N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 31 structure
31
吡虫啉杂质31Imidacloprid Impurity 31
Imidacloprid Impurity 31
CAS No.123342-91-6
Chemical FormulaC3H4N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 32 structure
32
吡虫啉杂质32Imidacloprid Impurity 32
Imidacloprid Impurity 32
CAS No.187022-17-9
Chemical FormulaC9H9ClN4
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 33 Monomer (Des Nitro-Imidacloprid) structure
33
吡虫啉杂质33 单体 (去硝基吡虫啉)Imidacloprid Impurity 33 Monomer (Des Nitro-Imidacloprid)
Imidacloprid Impurity 33 Monomer (Des Nitro-Imidacloprid)
CAS No.115970-17-7
Chemical FormulaC9H11ClN4
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 33 (Desnitro-Imidacloprid Hydrochloride) structure
33
吡虫啉杂质33 (盐酸去硝基吡虫啉)Imidacloprid Impurity 33 (Desnitro-Imidacloprid Hydrochloride)
Imidacloprid Impurity 33 (Desnitro-Imidacloprid Hydrochloride)
CAS No.127202-53-3
Chemical FormulaC9H11ClN4·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 34 (Thiacloprid) (Mixture of E/Z-isomers) structure
34
吡虫啉杂质34 (噻虫啉) (混合E/Z构型)Imidacloprid Impurity 34 (Thiacloprid) (Mixture of E/Z-isomers)
Imidacloprid Impurity 34 (Thiacloprid) (Mixture of E/Z-isomers)
CAS No.111988-49-9
Chemical FormulaC10H9ClN4S
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 35 structure
35
吡虫啉杂质35Imidacloprid Impurity 35
Imidacloprid Impurity 35
CAS No.1099598-08-9
Chemical FormulaC7H5ClF3N
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 36 structure
36
吡虫啉杂质36Imidacloprid Impurity 36
Imidacloprid Impurity 36
CAS No.677762-31-1
Chemical FormulaC7H6ClNO3
Purity>95%询价On request
10mg25mg50mg100mg
Imidacloprid Impurity 37 (N-Nitroso Imidacloprid Impurity 33 Monomer) structure
37
吡虫啉杂质37 (N-亚硝基吡虫啉杂质33 单体)Imidacloprid Impurity 37 (N-Nitroso Imidacloprid Impurity 33 Monomer)
Imidacloprid Impurity 37 (N-Nitroso Imidacloprid Impurity 33 Monomer)
CAS No.131206-85-4
Chemical FormulaC9H10ClN5O
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

吡虫啉 —— 研究文献与合成路线Imidacloprid — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 吡虫啉 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Imidacloprid. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Degradation of the neonicotinoid pesticide imidacloprid by electrocoagulation and ultrasound
    Halkijevic I, Licht K, Kosar V, et al. · Scientific reports · 2024 · 被引 3cited 3
  2. Integrated Study of Polyethylene Microplastic Degradation and Its Interaction with the Insecticide Imidacloprid: Chronic Toxicity to Daphnia similis
    Kiihl ME, da Silva Pinto TJ, Dias MA, et al. · Archives of environmental contamination and toxicology · 2026
  3. Humic acid promotes Fe(II) dynamics and hydroxyl radical generation via interfacial regulation on nanoscale zerovalent iron for imidacloprid degradation
    Chen D, Yi J, Guo Z, et al. · Water research · 2026
  4. Construction of phosphorus and cobalt co-modified tubular carbon nitride with dual reaction sites for boosted imidacloprid degradation
    Chen B, Zeng H, Zhang B, et al. · Journal of colloid and interface science · 2026
  5. Diversity of culturable gut bacteria associated with brown planthopper, Nilaparvata lugens (Stål) and their role in imidacloprid degradation
    Chowdary DD, Sridhar Y, Rao GR, et al. · Scientific reports · 2026
  6. Local control of S atoms on the Co-SACs for effective activation of PMS and degradation imidacloprid: Mechanism insights and toxicity evaluation
    Wang Z, Yang J, Lv G, et al. · Ecotoxicology and environmental safety · 2025

合成与制备工艺专利Synthesis & process patents

  1. Processing method for preparing imidacloprid wettable powder from crude imidacloprid
    FUCHUN HE, HONG YIN, LIN CHEN, GUANGCAI XUE, et al. · 公开号 CN101669467CN101669467 · 2010
  2. Process for the preparation of pesticide imidacloprid
    KANGISON D S QUINDANMUR H A PR · 公开号 CN101011057CN101011057 · 2007
  3. Method for synthesizing intermediate methyl pyridone of pesticide imidacloprid
    XIAOBI JING, LINTAO WU, QING WANG, XIAOXIN BI · 公开号 CN101628891CN101628891 · 2010
  4. Method for synthesizing olefin type imidacloprid from imidacloprid by microorganism transformation
    DAI YIJUN YUAN · 公开号 CN1763044CN1763044 · 2006
  5. Method for preparing thiocyclam and imidacloprid combined water dispersible powder
    JIANZHONG LIANG · 公开号 CN101313679CN101313679 · 2008

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

吡虫啉 杂质谱研究要点Imidacloprid — impurity profiling notes

下面这些是拿到 吡虫啉 的 24 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 24 impurity entries for Imidacloprid, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances